Early decrease in density of mononuclear leukocyte beta-adrenoceptors in depressed patients following amineptine...

Area of Science:

• Neuroscience
• Pharmacology
• Psychiatry

Background:

• Major unipolar depression is a complex mood disorder.
• Antidepressant mechanisms are not fully understood.
• Beta-adrenoceptor density on leukocytes has been explored as a biomarker.

Purpose of the Study:

• To investigate the effect of amineptine on beta-adrenoceptor density in depressed patients.
• To determine if changes in beta-adrenoceptor density correlate with clinical response.
• To assess the potential of beta-adrenoceptor density as a predictive index for antidepressant treatment.

Main Methods:

• Studied unmedicated major unipolar depressed patients undergoing chronic amineptine treatment (200mg/day).
• Measured specific binding of (-)-[125I]-iodopindolol to mononuclear leukocytes (MNL) at baseline (D0), after one week (D7), and one month (D28).
• Assessed clinical improvement using the AMDP-depression scale.

Main Results:

• Patients showed significant clinical improvement by D7.
• A significant decrease (33%) in beta-adrenoceptor density (Bmax) was observed at D7 in responders, remaining lower at D28.
• No significant changes in beta-receptor affinity (Kd) were detected.
• Two patients relapsed by D28, considered non-responders.

Conclusions:

• Amineptine treatment rapidly affects MNL beta-adrenoceptor density.
• Reduced MNL beta-adrenoceptor density is associated with stable clinical improvement.
• MNL beta-adrenoceptor density may serve as a predictive index for successful antidepressant treatment with amineptine.